Thursday, July 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
FDA CLEAREDEasyWhip Family — Winter Innovations, Inc.2 weeks agoFDA CLEAREDLED Neck Beauty Mask (ZLD-66A,ZLD-90E,ZLD-130,ZLD-180H) — Shenzhen Kaiyan Medical Equipment Co., Ltd.4 weeks agoFDA CLEAREDLUTRONIC GENIUS — Cynosure Lutronic Technology Corporation2 weeks agoFDA CLEAREDPICOSURE WORKSTATION — Cynosure, LLC4 weeks agoFDA CLEAREDLED Light Therapy Masks (LED Face Mask Pro FAC08NA, LED Chest Mask Pro FAC09NA) — Guangdong Newdermo Biotech Co., Ltd.2 weeks agoFDA CLEAREDCoolSeal Generator® (CSL-200-90) — Hologic, Inc.4 weeks agoFDA CLEAREDHemolase Fiber (Hemo-R-0.40-2.5/Hemo-R-0.60-2.5/Hemo-R-0.40-1.8/Hemo-R-0.60-1.8) — Micro-Energy Medical Technology Co., Ltd.4 weeks agoFDA CLEAREDLED Light Therapy Mask (K9C-TK, K9C-K, K9P-YK, K9P-K, FM-03BK, FM-09K) — Guangdong Newdermo Biotech Co., Ltd.4 weeks ago
1 free article left this week. A free account gets you 4 a week.Go Pro →
Business & M&A

Court Bid Filed to Pause InMode Takeover Review — Shareholder Litigation Clouds Steel Partners Offer

Legal challenge to InMode's acquisition process introduces execution risk and potential delays to the Steel Partners deal.

Image: Inside MedSpa

A shareholder has filed a court motion seeking to pause InMode's review of the Steel Partners acquisition proposal, alleging procedural defects or conflicts of interest in the board's evaluation process. Such litigation is routine in M&A transactions but introduces execution risk and potential deal delays.

The motion likely centers on board independence, process fairness, or disclosure adequacy—standard shareholder-protection arguments. If granted, the pause could extend the review timeline, allowing competing bidders to emerge or forcing renegotiation of the Steel Partners offer. InMode's board will defend the process and seek expedited resolution.

Shareholder litigation seeking to pause InMode's takeover review introduces execution risk and potential deal delays.

For practice owners holding InMode stock or considering device purchases, the litigation adds uncertainty but does not materially change the underlying business. However, prolonged M&A uncertainty can slow capital deployment and R&D investment. Monitor the August 5 earnings call for board commentary on the legal challenge and timeline expectations. A swift resolution (favorable or not) is preferable to prolonged limbo.

Source: original report ↗

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/inmode-court-bid-pause-takeover-review/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo